HIV protease inhibitor BMS-232632-05, Purity ≥98%

Synonym: 229975-97-7; HIV protease inhibitor; BMS-232632-05; CGP-73547; Reyataz; Zrivada

MDL: MFCD08067748
CAS Number: 229975-97-7
Compound CID: 158550

Product Size

5 mg; 10 mg; 25 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

BMS-232632-05, soluble in DMSO and insoluble in ethanol and water, blocks the protease enzyme, essential for the maturation and replication of HIV, playing a key role in highly active antiretroviral therapy (HAART). It targets HIV protease.

Molecular Weight

802.9

Molecular Formula

C₃₈H₅₂N₆O₇.H₂SO₄

Targets

HIV protease: 2.66 nM (Ki)

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 92 mg/mL (114.58 mM); Water: Insoluble; Ethanol: Insoluble

Identity

Confirmed by NMR/HPLC/MS.

Applications

BMS-232632-05 is used to inhibit HIV protease, an essential enzyme in the life cycle of the virus, aiding in antiretroviral therapy research.